Historical Background

The first steps to create an organisation devoted to vascular causes of cognitive and behavioural disorders were taken during autumn 2001 when researchers started to discuss the need to have a society which could organise meetings and working groups. The discussions became more formal at a meeting in Madrid later that year in November on Vascular Burden of the Brain: New Therapeutic Directions, organised by the International Psychogeriatric Association.

At that meeting a manifesto was drafted (see below) and sent out to researchers interested in the subject. This manifesto was soon signed by a large number of researchers from different parts of the world (see Founding members). It was also decided that the first meeting was to be held in Gothenburg, Sweden in August 2003 (VASCOG 2003).

During spring 2002, after discussions and a final voting among the founding members, it was decided that the name of the society should be the International Society for Vascular Behavioural and Cognitive Disorders (VasCog). In April 2002, at the 3rd World Congress on Vascular factors in Alzheimer's Disease held in Kyoto, Japan, it was decided that in future this Congress should be incorporated into the VasCog meetings.

During autumn 2002 the members of the Society discussed and finally approved the by-laws of the society, first drafted by Julien Bogousslavsky and Ingmar Skoog.

During Spring 2003 the members decided after voting that the 2nd Congress should be held in Florence, Italy 2005. The first Executive Committee of Vas-Cog was elected during the summer of 2003, and had its first meeting during VASCOG 2003 in Gothenburg.


To investigate vascular factors related to brain injury and dysfunction through their manifold causes and presentations and to strive for consensus on vascular involvement in psychiatric, psychological, cognitive, behavioural, and functional symptoms.

The principle goal of the society is to raise awareness through regular scientific meetings on the topic and facilitate the attendance of younger researchers at such meetings.


  • Encourage worldwide representation
  • Involve a multidisciplinary approach
  • Stimulate research and debate
  • Encourage integration and participation of young researchers
  • Disseminate and translate results to clinical practice
  • Advance public education and awareness
  • Develop liaison with caregivers


  • Organise and host biennial international meetings
  • Hold focused workshops